Stamford, CT -- (SBWIRE) -- 10/01/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: China Sunergy Co Ltd (NASDAQ:CSUN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Celldex Therapeutics, Inc. (NASDAQ:CLDX), MAKO Surgical Corp. (NASDAQ:MAKO)
China Sunergy Co Ltd (NASDAQ:CSUN) ended higher +42.76% and complete the day at $6.01. The total number of shares changed hands during the day was 7.93 million. After opening at $4.14, the stock hit as high as $6.95. However, it traded between $1.03 and $6.95 over the last twelve months. China Sunergy Co., Ltd., together with its subsidiaries, engages in the design, development, manufacture, and marketing of solar cells and modules in the People?s Republic of China and internationally.
For How Long CSUN will Fight for Profitability? Read This Trend Analysis report
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) closed yesterday at $27.47, a +1.63% increase. Around 4.37 million shares were traded, beating an-average trading volume of 1.69 million shares. The company is now valued at around $2.44 billion. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders.
For How Long ACAD’s Gloss will Attract Investors? Find out via this report
Celldex Therapeutics, Inc. (NASDAQ:CLDX) moved -1.61 percent lower at $35.43 and traded between $32.20 and $36.91 after opening the day at $34.53. Its performance over the last five days remained +22.34%, which stands at +63.12% for a month. Going back further than one month, 1-year performance after recent close was +428.02%. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Why Should Investors Buy CLDX After the Recent Fall? Just Go Here and Find Out
MAKO Surgical Corp. (NASDAQ:MAKO)’s shares rose, +0.10 percent to close at $29.51. The stock is up around +129.65% this year and +69.5% for the last 12 months. Around 3.01 million shares changed hands yesterday, higher from an-average trading volume of 2.58 million shares. MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally.
Why Should Investors Buy MAKO After The Recent Gain? Just Go Here and Find Out
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)